SCHEMBL2908029

SCHEMBL2908029

Nc1nc(NCCCn2cc(C(=O)O)c(-c3ccc(Br)cc3F)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.37
GSK3A P49840 3/20 0.37
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
CDK1 P06493 2/20 0.35
CCNB2 O95067 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNB3 Q8WWL7 1/20 0.34
CDK2 P24941 1/20 0.33
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
FOLH1 Q04609 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
SIRT5 Q9NXA8 1/20 0.31
EIF4E P06730 1/20 0.31
AXL P30530 2/20 0.31
MERTK Q12866 2/20 0.31
MAP2K1 Q02750 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912304 0.92 GSK3B (0.38) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2906807 0.90 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911576 0.89 GSK3B (0.36) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910776 0.89 MAPT (0.37) GSK3BGSK3AAKR1C2AKR1C1CDK1
SCHEMBL2909714 0.87 GSK3B (0.36) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2944754 0.87 ALOX5AP (0.35) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912314 0.87 GSK3B (0.35) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2905628 0.87 ALOX5AP (0.35) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911304 0.87 GSK3B (0.35) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2906887 0.85 GSK3B (0.43) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed